"Insomnia - Pipeline Assessment and Market Forecasts to 2017" now available at Fast Market Research

Nov. 17, 2010 - PRLog -- GlobalData, the industry analysis specialist, has released its new report, "Insomnia - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Insomnia market. The report identifies the key trends shaping and driving the global Insomnia market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Insomnia sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData estimated the global insomnia market to be valued at $2.75 billion in 2009. It is forecast to decline at a Compound Annual Growth Rate (CAGR) of -3.2% over the next seven years to reach $2.12 billion by 2017. The decline will be mainly due to the patent expiry of many drugs. Barriers to the insomnia market are strong in terms of both pricing (generics and me-too compounds in the market) and volume, with issues such as the low treatment-seeking rate and a low diagnosis rate, amongst others

Scope

The report provides information on the key drivers and challenges of the Insomnia market. Its scope includes:  

* Annualized global Insomnia market revenues data from 2001 to 2009, forecast for eight years to 2017.
* Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends. Pipeline candidates fall under major therapeutic classes such as Serotonin receptor antagonists, Melatonin receptor agonists, GABA receptor modulators, Orexin receptor antagonists, 5-HT2A and histamine receptor antagonists and Phosphoprotien  modulators.
* Analysis of the current and future competition in the global Insomnia market. Key market players covered are Bayer Healtcare Pharmaceuticals, Pfizer Inc, GlaxoSmithKline, Takeda Pharmaceuticals, Actelion Ltd., Eli Lilly and Company and Vanda Pharmaceuticals.
* Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
* Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Insomnia  therapeutics market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to:

* Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
* Develop business strategies by understanding the trends shaping and driving the global Insomnia market.
* Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Insomnia market in future.
* Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
* Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
* Organize your sales and marketing efforts by identifying the market categories and segments that present maximum best opportunities for consolidations, investments and strategic partnerships.
* What's the next big thing in the global Insomnia insomnia market landscape? - Identify, understand and capitalize.


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/92033_insomnia_pipeline_assess...


Partial Table of Contents:

1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Insomnia Therapeutics: Introduction 6
2.1 GlobalData Pipeline Report Guidance 7
3 Insomnia Therapeutics: Market Characterization 8
3.1 Insomnia Market Size 8
3.2 Insomnia Market Forecast and CAGR 9
3.3 Drivers and Barriers for the Insomnia Market 10
3.3.1 Drivers for the Insomnia Market 10
3.3.2 Barriers for the Insomnia Market 10
3.4 Opportunity and Unmet Need 11
3.5 Key Takeaway 12
4 Insomnia Market: Competitive Assessment 13
4.1 Overview 13
4.2 Strategic Competitor Assessment 13
4.3 Product Sales for Major Insomnia Products 14
4.4 Product Profile for the Major Marketed Products in the Insomnia Market 14
4.4.1 Ambien CR (zolpidem tartrate extended-release) 14
4.4.2 Lunesta 15
4.4.3 Paxil (Paroxetine) 16
4.5 Other Marketed Products for the Insomnia Market 17
4.5.1 Zolpimist (zolpidem oral spray) 17
4.5.2 Edluar (zolpidem sublingual tablets) 18
4.5.3 Circadin (prolonged release melatonin) 18
4.6 Key Takeaway 19
5 Insomnia Market: Pipeline Assessment 20
5.1 Overview 20
5.2 Strategic Pipeline Assessment 20
5.2.1 Technology Trends Analytic Framework 20
5.3 Insomnia Therapeutics - Promising Drugs under Clinical Development 22
5.4 Molecule Profile for Promising Drugs under Clinical Development 23
5.4.1 Ciltyri (eplivanserin) 23
5.4.2 Almorexant 23
5.4.3 Silenor (doxepin hydrochloride) 24
5.4.4 Tasimelteon (VEC-162) 25
5.4.5 Esmirtazapine (ORG 50081) 25
5.4.6 Indiplon 26
5.5 Insomnia Therapeutics Market - Clinical Pipeline by Mechanism of Action 27
5.6 Insomnia Pipeline - Pipeline by Clinical Phases of Development 28
5.6.1 Insomnia Therapeutics - Regulatory and Phase III Clinical Pipeline 28
5.6.2 Insomnia Therapeutics - Phase II Clinical Pipeline 29
5.6.3 Insomnia Therapeutics - Phase I Clinical Pipeline 30
5.6.4 Insomnia Therapeutics - Preclinical Pipeline 30
5.6.5 Insomnia Therapeutics - Discovery Pipeline 30
5.7 Discontinued / Suspended Drugs for Insomnia 31
5.8 Key Takeaway 32
6 Insomnia Market: Implications for Future Market Competition 33
7 Insomnia Market: Future Players in Insomnia Market 34
7.1 Introduction 34
7.2 GlaxoSmithKline 35
7.2.1 Overview 35
7.2.2 CNS Portfolio 35
7.2.3 Insomnia Product Portfolio 37

Full Table of Contents is available at:
-- http://www.fastmr.com/catalog/product.aspx?productid=9203...

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.  View more research from GlobalData at http://www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.